Back
Sarepta Therapeutics Vs. Gilead Sciences Industry Stock Comparison
Sell
26
SRPT
Sarepta Therapeutics
Last Price:
120.15
Seasonality Move:
-0.82%
Buy
58
GILD
Gilead Sciences
Last Price:
84.59
Seasonality Move:
5.63%
Sell
26
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $120.40. The Score for SRPT is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $84.59. The Score for GILD is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- GILD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $120.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $84.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GILD is experiencing slight buying pressure.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.41 | Sell |
Relative Strength Index (14 RSI): | 32.45 | Sell |
Chaikin Money Flow: | 79309 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (122.31 - 130.81) | Sell |
Bollinger Bands (100): | (122.97 - 147.31) | Sell |
GILD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.63 | Buy |
Relative Strength Index (14 RSI): | 67.78 | Buy |
Chaikin Money Flow: | 982486 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (80.33 - 84.37) | Buy |
Bollinger Bands (100): | (66.74 - 80.04) | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.86 | Sell |
20-day SMA: | 124.78 | Sell |
50-day SMA: | 132.71 | Sell |
200-day SMA: | 128.28 | Sell |
8-day EMA: | 122.39 | Sell |
20-day EMA: | 125.48 | Sell |
50-day EMA: | 130.61 | Sell |
200-day EMA: | 128.3 | Sell |
GILD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 83.77 | Buy |
20-day SMA: | 83.17 | Buy |
50-day SMA: | 79.03 | Buy |
200-day SMA: | 73.78 | Buy |
8-day EMA: | 84.01 | Buy |
20-day EMA: | 82.75 | Buy |
50-day EMA: | 79.35 | Buy |
200-day EMA: | 74.9 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.41 per share, and an increase next year of $9.14 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.96 per share, and an increase next year of $3.34 per share.
Sarepta Therapeutics Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Gilead Sciences Technical Analysis
Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | Oct | |||||||||
23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |